Valvular heart disease in a man with Parkinson’s disease

Daniel G. Baseman, Sharon C Reimold, Richard B Dewey

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

CASE PRESENTATION A 62-year-old man was diagnosed with Parkinson’s disease in 1993 and treated with amantadine, benztropine, and carbidopa/levodopa. Three years later, due to adverse effects and inadequate efficacy, amantadine and benztropine were eliminated and pergolide was begun. Within 9 months, the dose of pergolide was adjusted to 1 mg three times daily and he was able to reduce the dose of controlled/release carbidopa-levodopa 50/200 from one to one-half tablet three times a day. Following the addition of pergolide, his left hand resting tremor and rigidity resolved and his left hand bradykinesia improved.

Original languageEnglish (US)
Title of host publicationMovement Disorders
Subtitle of host publication100 Instructive Cases
PublisherCRC Press
Pages223-225
Number of pages3
ISBN (Electronic)9780203008454
ISBN (Print)1841845248, 9781841845241
StatePublished - Jan 1 2008

Fingerprint

Pergolide
Heart Valve Diseases
Benztropine
Parkinson Disease
Amantadine
Hand
Hypokinesia
Tremor
Tablets
levodopa drug combination carbidopa

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Baseman, D. G., Reimold, S. C., & Dewey, R. B. (2008). Valvular heart disease in a man with Parkinson’s disease. In Movement Disorders: 100 Instructive Cases (pp. 223-225). CRC Press.

Valvular heart disease in a man with Parkinson’s disease. / Baseman, Daniel G.; Reimold, Sharon C; Dewey, Richard B.

Movement Disorders: 100 Instructive Cases. CRC Press, 2008. p. 223-225.

Research output: Chapter in Book/Report/Conference proceedingChapter

Baseman, DG, Reimold, SC & Dewey, RB 2008, Valvular heart disease in a man with Parkinson’s disease. in Movement Disorders: 100 Instructive Cases. CRC Press, pp. 223-225.
Baseman DG, Reimold SC, Dewey RB. Valvular heart disease in a man with Parkinson’s disease. In Movement Disorders: 100 Instructive Cases. CRC Press. 2008. p. 223-225
Baseman, Daniel G. ; Reimold, Sharon C ; Dewey, Richard B. / Valvular heart disease in a man with Parkinson’s disease. Movement Disorders: 100 Instructive Cases. CRC Press, 2008. pp. 223-225
@inbook{5b23d30c3046472f98fd8092fcaa5a19,
title = "Valvular heart disease in a man with Parkinson’s disease",
abstract = "CASE PRESENTATION A 62-year-old man was diagnosed with Parkinson’s disease in 1993 and treated with amantadine, benztropine, and carbidopa/levodopa. Three years later, due to adverse effects and inadequate efficacy, amantadine and benztropine were eliminated and pergolide was begun. Within 9 months, the dose of pergolide was adjusted to 1 mg three times daily and he was able to reduce the dose of controlled/release carbidopa-levodopa 50/200 from one to one-half tablet three times a day. Following the addition of pergolide, his left hand resting tremor and rigidity resolved and his left hand bradykinesia improved.",
author = "Baseman, {Daniel G.} and Reimold, {Sharon C} and Dewey, {Richard B}",
year = "2008",
month = "1",
day = "1",
language = "English (US)",
isbn = "1841845248",
pages = "223--225",
booktitle = "Movement Disorders",
publisher = "CRC Press",

}

TY - CHAP

T1 - Valvular heart disease in a man with Parkinson’s disease

AU - Baseman, Daniel G.

AU - Reimold, Sharon C

AU - Dewey, Richard B

PY - 2008/1/1

Y1 - 2008/1/1

N2 - CASE PRESENTATION A 62-year-old man was diagnosed with Parkinson’s disease in 1993 and treated with amantadine, benztropine, and carbidopa/levodopa. Three years later, due to adverse effects and inadequate efficacy, amantadine and benztropine were eliminated and pergolide was begun. Within 9 months, the dose of pergolide was adjusted to 1 mg three times daily and he was able to reduce the dose of controlled/release carbidopa-levodopa 50/200 from one to one-half tablet three times a day. Following the addition of pergolide, his left hand resting tremor and rigidity resolved and his left hand bradykinesia improved.

AB - CASE PRESENTATION A 62-year-old man was diagnosed with Parkinson’s disease in 1993 and treated with amantadine, benztropine, and carbidopa/levodopa. Three years later, due to adverse effects and inadequate efficacy, amantadine and benztropine were eliminated and pergolide was begun. Within 9 months, the dose of pergolide was adjusted to 1 mg three times daily and he was able to reduce the dose of controlled/release carbidopa-levodopa 50/200 from one to one-half tablet three times a day. Following the addition of pergolide, his left hand resting tremor and rigidity resolved and his left hand bradykinesia improved.

UR - http://www.scopus.com/inward/record.url?scp=85056348637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056348637&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85056348637

SN - 1841845248

SN - 9781841845241

SP - 223

EP - 225

BT - Movement Disorders

PB - CRC Press

ER -